The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): Quality of Life and Psychological Functioning in Patients Receiving Cardiac Resynchronization Therapy

Ford, Jessica; Sears, Samuel F.; Ramza, Brian; Reynolds, Dwight; Nguyen, P.; Fedewa, Michelle M.; House, John A.; Kennedy, Paul; R, Thompson; Murray, Christina M.

doi:10.1111/jce.12257

Cited by 11 publications

(7 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our findings are consistent with previous data reporting the incidence of depression between 20 and 65% [2,4,13]. The high prevalence of depression in patients with severe HF should not be surprising, given the fact that high NYHA class is one of the essential predictors of worse psychological functioning [13,14]. However, in contrast to previous studies, it is important to note that we diagnosed depression in a 2-step protocol - first a self-reported patient questionnaire was to be completed and secondly the diagnosis was further verified clinically by a psychiatrist, and only upon that assessment finally confirmed or not.…”

Section: Discussionsupporting

confidence: 83%

Section: Discussionsupporting

confidence: 82%

“…However, in contrast to previous studies, it is important to note that we diagnosed depression in a 2-step protocol - first a self-reported patient questionnaire was to be completed and secondly the diagnosis was further verified clinically by a psychiatrist, and only upon that assessment finally confirmed or not. This is of great importance as the majority of previous studies used only a self-reported survey as the diagnostic tool for the diagnosis of depression [13,15], and such an approach may significantly influence the reliability of diagnosing depression. Secondly, patient self-reporting by itself does not allow a nonpsychiatrist to diagnose depression and subsequently initiate antidepressant therapy.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients

et al. 2017

View full text Add to dashboard Cite

Objectives: Chronic heart failure (HF) is associated with significantly increased prevalence of depression. The aim of the study was to assess the incidence and clinical impact of depression as well as the effectiveness of depression treatment in HF patients. Methods: A prospective interventional trial included 285 consecutive cardiac resynchronization therapy recipients. Patients underwent a psychiatric examination at the time of implantation and then it was routinely repeated at 3, 6, and 12 months after the procedure, and every 6 months thereafter. One hundred and thirty-five (47.4%) patients with depression were included in the depression group, whereas the control group was comprised of 150 patients free of depression. Sixty-eight (50.4%) subjects received antidepressants (treated group), whereas the observational group had 67 (49.6%) depressed patients who refused to take antidepressants. Results: Depression remission was achieved in 51 (75.0%) patients from the treated group. Long-term mortality and HF hospitalization rates were significantly higher in the depression group than in the control group (20.7 vs. 11.3% and 32.6 vs. 19.2%, respectively). However, remission from depression was associated with a 40% reduction in the relative risk of major adverse cardiac events (MACE). Conclusions: Patients with HF and concomitant depression are at higher risk of MACE compared with those free of depression. Effective antidepressant treatment may significantly improve long-term outcomes in this population.

show abstract

Section: Discussionsupporting

confidence: 83%

Section: Discussionsupporting

confidence: 82%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Regarding shock response, FSAS scores increased with incidence of appropriate and inappropriate shocks among patients implanted with ICDs newly programmed to reduce number of inappropriate shocks . There were no significant differences in FSAS score over time between patients with ICDs and those who underwent cardiac resynchronization therapy . In Sears et al.…”

Section: Resultsmentioning

confidence: 95%

“…5 There were no significant differences in FSAS score over time between patients with ICDs and those who underwent cardiac resynchronization therapy. 22 for reducing ICD-related distress, including FSAS score. 13,14,25,26 Individual and group differences in FSAS scores may reveal subgroups with psychological treatment needs.…”

Section: Correlates Of Shock Anxietymentioning

confidence: 99%

Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use

Tripp

Huber

Kuhl³

et al. 2019

Pacing Clinical Electrophis

View full text Add to dashboard Cite

Introduction Approximately 44% of patients with implantable cardioverter defibrillators (ICDs) experience some form of shock anxiety, associated with cardiac fear, physical inactivity, and increased morbidity and mortality. The Florida Shock Anxiety Scale (FSAS) was created to measure ICD‐specific fears for a more precise target of patient psychologic distress and potential need for intervention. The current paper describes results from a focused literature review of studies using FSAS over the past 15 years, with the aim of summarizing its current reliability and validity, associated outcomes, and potential future directions for its clinical and research implementation. Methods In this review, 26 peer‐reviewed articles were analyzed and selected from an in‐depth literature search of two electronic databases. Results The reliability and validity of FSAS has been upheld since its initial validation and remain positive. The majority of studies used FSAS as an assessment tool to evaluate a clinical need for psychologic support or psychoeducation. The most frequently reported predictors of FSAS shock anxiety include experience of shock, appropriate and inappropriate, and number of shocks experienced. Common correlates of higher FSAS scores include lower device‐related knowledge, lower perceived support from healthcare providers, greater posttraumatic stress disorder symptoms, and negative attitudes about device dependency. Younger age and female gender are also associated with increased shock anxiety. Conclusions Since 2006, FSAS has been widely represented as a valid and reliable assessment tool for quantifying device‐related anxiety in ICD recipients in diverse populations. Future directions for FSAS should explore its potential role in support of measurement‐based care.

show abstract

Psychological Consultation for Patients with Implantable Cardioverter Defibrillator: Confounding Challenges of Cardiac Disease, Technology, and the Patient Experience

Whited¹,

Sears²,

Cahill³

et al. 2016

Handbook of Psychocardiology

View full text Add to dashboard Cite

The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): Quality of Life and Psychological Functioning in Patients Receiving Cardiac Resynchronization Therapy

Abstract: Evidence of low QoL, psychological functioning, and device acceptance provides the impetus to increase research on well-being of HF patients being implanted with CRTD in research and clinical work.

Cited by 11 publications

References 28 publications

The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients

The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients

Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use

Psychological Consultation for Patients with Implantable Cardioverter Defibrillator: Confounding Challenges of Cardiac Disease, Technology, and the Patient Experience

Contact Info

Product

Resources

About